SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001123292-20-001261
Filing Date
2020-12-16
Accepted
2020-12-15 18:59:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 pdlbiopharma13g_12152020.htm SC 13G 164475
  Complete submission text file 0001123292-20-001261.txt   166058
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43256 | Film No.: 201390803
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830 (203) 542-4000
Silver Point Capital L.P. (Filed by) CIK: 0001332784 (see all company filings)

IRS No.: 223844936 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G